Coty COTY Q1 2026 Earnings Miss EPS 003 vs 000 Expected Five9 FIVN Stock Analysis Climbs 429 Eyes on 2272 20260515 Japans SBI and Rakuten Expand Crypto Offerings with InHouse Investment Trusts Tango Therapeutics TNGX Declines 1733 Amid Market Weakness 20260515 EOG Resources Surges in Q1 as Oil Prices and Operational Strength Drive Investor Optimism Wholesale Inflation Accelerates April PPI Posts 6 Annual Gain Largest Since 2022 Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives Pfizer Clinches Trademark Victory in Singapore Against Merck Over Vaccine Brand Nokia NOK Secures UK Appeal Victory in Video Patent Dispute with Acer and Asus Consumer Reports Testing Highlights Filtration Trends Vacuum Market May Shift Toward AllergyFriendly Models MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected ClearOne CLRO Q2 2018 Earnings Narrowing Losses Exceeds Analyst Expectations VRTS Q1 2026 Earnings Earnings Miss Estimates Amid Market Headwinds Stock Edges Higher BKV Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed SRTA Q1 2026 Earnings Surprise Profitability Despite No Reported Revenue Mativ Holdings MATV Q1 2026 Earnings EPS Surge of 194 Surprise Despite Flat Revenue Outlook ARTCW Warrants Hold Steady at 035 Amid Tight Trading Range Ryman Hospitality Properties RHP Hovers Near Support as Hospitality Sector Faces Headwinds Viemed Healthcare VMD Shows Modest Gains Tests Key Resistance Zone AO Smith AOS Holds Near Support as Stock Slips 055 AEye Inc LIDR Gains 37 as Shares Approach Key Resistance Intercorp Financial Services IFS Edges Lower by 087 as Stock Approaches Support Zone Mechanics Bancorp MCHB Edges Higher Stability Amid Tight Trading Range FiscalNote Holdings NOTE Holds Steady at 020 Key Levels in Focus ATT T Holds Steady Near 25 as Traders Eye Support and Resistance Levels Culp Inc CULP Holds Steady Near Support as Traders Eye Key Resistance Chinese Drone Shipments Plunge Amid Domestic Crackdown and US Import Ban VNDA Q1 2026 Earnings EPS Misses Estimates as Losses Widen Stock Slides Larimar Therapeutics LRMR Holds Steady Near Support After Modest Gain